https://iacs-13909inhibitor.co....m/bilateral-nephrobl
The median age at analysis was 64 and 84.8% of women had serous carcinoma. We identified 105 women (19.7%) on a beta-blocker of whom 94 (90%) had been on a cardioselective beta-blocker. Furthermore, 24 females (4.5%) were on metformin, 91 (17%) on aspirin, and 128 (24%) on a statin. In univariable evaluation, beta-blocker users had a median total survival of 29 months vs 35 months among non-users (risk ratio HR = 1.52, p = 0.007). After adjustment for crucial demographic, cli
Like
Comment
Share
